The role of myeloid-derived suppressor cells in hematologic malignancies.

Current Opinion in Oncology
Emine Gulsen GunesChristiane Querfeld

Abstract

This article focuses on the immunosuppressive impact of myeloid-derived suppressor cells (MDSCs) and the potential clinical implications in hematological malignancies. MDSCs play a critical role in the regulation of the immune response in cancer. They inhibit activation of adaptive immune response and as a result foster the growth of the malignancy. Recent studies have shown that MDSCs serve as prognostic biomarkers and as targets for cancer immunotherapy. Preclinical and clinical studies have identified new approaches to deplete MDSC populations and inhibit MDSC function with combination immunomodulatory therapies including chemotherapeutic agents with immune checkpoint-directed treatment. A broad spectrum of publications indicate that direct targeting of MDSCs may abrogate their protumorigenic impact within the tumor microenvironment through activation of the adaptive immune response.

References

Sep 29, 2001·Nature Immunology·C Bogdan
Sep 28, 2005·The Journal of Experimental Medicine·Paulo C RodriguezAugusto C Ochoa
May 4, 2007·The Journal of Clinical Investigation·Antonio Sica, Vincenzo Bronte
May 8, 2007·Cancer Research·Pratima SinhaSuzanne Ostrand-Rosenberg
Aug 10, 2007·British Journal of Haematology·Guy PrattPaul Moss
Nov 17, 2007·Cancer Research·Yulia NefedovaDmitry I Gabrilovich
Oct 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Je-In YounDmitry I Gabrilovich
Dec 26, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hequan LiXuetao Cao
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Mar 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer S KoJames H Finke
Apr 24, 2010·Cancer Immunology, Immunotherapy : CII·Suzanne Ostrand-Rosenberg
Aug 13, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Krithika N KodumudiJulie Y Djeu
Sep 21, 2011·The Journal of Experimental Medicine·Barbara MolonAntonella Viola
Nov 15, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jahyang ChoiDae Seog Heo
Jan 3, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marianna IoannouPanayotis Verginis
Feb 7, 2012·Journal of Immunotherapy·Alberto J MonteroSusanna Mandruzzato
Mar 23, 2012·Nature Reviews. Immunology·Dmitry I GabrilovichVincenzo Bronte
Jul 4, 2012·Oncoimmunology·Scott I Abrams, Jeremy D Waight
Sep 29, 2012·Immunological Investigations·Nataša ObermajerPawel Kalinski
Mar 6, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Indu R RamachandranYulia Nefedova
Oct 18, 2013·Nature Reviews. Cancer·Michael PickupHarold L Moses

❮ Previous
Next ❯

Citations

May 1, 2021·Journal of Clinical Medicine·Alejandro Olivares-HernándezJosé Pablo Miramontes-González
Jun 3, 2021·Cancers·Mélody CaillotBrigitte Sola

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

© 2021 Meta ULC. All rights reserved